Vanguard Group »

Neurogene shares owned by Vanguard Group

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $977k 50k 19.38